Long-term immune deficiency after allogeneic stem cell transplantation: B cell deficiency is associated with late infections
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INTRODUCTION
Immune reconstitution has emerged as a general concern in hematopoietic stem cell transplantation (HSCT). After resolution of peri-transplantation neutropenia infections ranged from 40% to nearly 80% (1) . In contrast to the relatively early recovery of innate immunity, all, but especially adult, recipients of an allogeneic HSCT experience post-transplant deficiencies in B and T cell reconstitution. This delay in function recovery may persist for more than 1 year (1) (2) (3) (4) . Although the T-cell component of the immune defect has been relatively well defined, the B-cell component is less well known, in the long-term. The majority of current studies focus on immune parameters measured sequentially to 1-year post-transplant (3, (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . We previously reported a study aimed at evaluating the long-term immune reconstitution after allogeneic HSCT using standard immune parameters (CD3, CD4, CD8 and NK cells) (18) . However since the early 2000's significant progress has been made in molecular HLA-typing and in the treatment of viral and fungal infections. Furthermore advances in basic immunology have added complexities in the definition of phenotypes with introduction of naïve and memory subtypes. This new study takes into consideration these clinical and biological advances to reassess the long-term immune deficiency after allogeneic HSCT.
Design and Methods
One hundred and forty consecutive patients are included in this study. All underwent transplantation at the Hospital Saint Louis Paris, between 1995 and 2005. The selection criterion was being alive, without relapse, after a myeloablative conditioning for more than 2 years with available sequential routine immune-reconstitution analyses. This is thus a highly selected population of patients who did not die during the first 2 years of either GvHD and/or of infections. Patients who received cord blood cells transplantation were excluded. Median follow up was 48 months. Median age was 27 years at transplant with 39 children and 101 adults. Patients-, disease-and © F e r r a t a S t o r t i F o u n d a t i o n transplant-characteristics of the patients are summarized in Table 1 . Our policy concerning microbial prophylaxis has been previously reported in details (19) , and is summarized in supplementary data on line.
The study was performed in accordance with the Helsinki declaration as part of routine immunological follow-up, after approval by the IRB of the Hospital St Louis.
T CD3, CD4 and CD8, B and NK lymphocytes were enumerated in fresh whole blood EDTA samples by direct 3 or 4-colour immunofluorescence with a Facscalibur analyser (Becton Dickinson, San José, California, USA) as previously described (18) . Percentages and absolute counts were determined. 10 4 lymphocytes were gated and competent (CD28+), naïve (CD45RA+CD62L+), memory (CD45RO) CD4 and CD8 T cells, CD5+CD19+, naïve (CD27-) and memory (CD27+) CD19+ B cells were analysed. Isotypic controls were performed simultaneously. Antibodies used were CD45-PerCP or -FITC, CD14-PE, CD3-FITC or -PerCP, CD4-APC, CD8-PerCP or -PE, CD28-PE, CD45RO-PE, CD16+56-PE, CD19-FITC, from Becton Dickinson, CD45RA-APC, CD27 PE (from Pharmingen, San Diego, CA, USA); CD5-PE-Cy5 (Immunotech Coulter Beckman, Fullerton, CA, USA). Lymphocyte subset populations for each patient were quantified 3, 6, 12, 24 months after transplant.
The main clinical outcome post transplant we studied was severe late infection Severe infections definition was as previously described (19) and summarized in supplementary data on line.
Univariate and multivariate statistical methods were used to analyze the process of reconstitution of lymphocyte subsets according to clinical parameters in the posttransplant period. A logarithmic transformation was done to normalize quantitative data. Non-parametric and parametric tests were used where appropriate. To compare lymphocyte subset populations according to clinical parameters, KruskalWallis test was used for crude data and ANOVA for transformed data. Due to multiple comparisons and low numbers in some subsets only p value <.01 were deemed significant. Differences for categorical variables between 2 groups were evaluated by c 2 (with Yates correction if needed) or Fisher test. Cumulative incidence using competing risk method was used to assess prognostic factors of severe late infections with death or relapse as a competing event. Cox proportional hazard model was used in multivariate analyses of risk factors for late infections. A stepwise backward procedure was use to construct a set of independent predictors of each end point All predictors achieved a P value below 0.15 were considered and sequentially removed if the P value in the multiple model was above 0.05. The proportional hazard assumption was checked by graphical method. C.GVHD was always introduced in the models as a time dependant variable. Other variables were age, donor related or not, TBI, malignant disease and source of cells. All tests were two-sided, with type I error rate fixed at 0.01 except for Cox analysis (p =0.05).
Statistical analyses were performed with SPSS 15 and Stata® 10 software. The R package: "cmprsk" developed by Fine and Gray was used to evaluate competing risks.
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RESULTS AND DISCUSSION
Long-term analyses of lymphocytes subsets reconstitution
Patients had long lasting lymphopenia. T-lymphocytes (CD3+) normalized only by 24 months overall with an earlier recovery of CD8+ than CD4+ T-cell. In contrast patients exhibited an early NK-cells recovery and an early expansion of the CD19+CD5+ subset within CD19+ B-cells (supplementary figure 1 on line) . The analysis of CD4 and CD8 subsets revealed a yet poorly described pattern of recovery on the long term. Naïve, terminally differentiated and memory CD8 cells did not normalize till 24 months post-transplantation (figure 1). In contrast, HLA-DR+ activated CD8+ T cells expanded early after transplant with values above our normal range from 3 months till 2 years post transplantation (figure 1). Similarly naïve, terminally differentiated and memory CD4 T cells did not normalize till 24 months post-transplantation (figure 1) while activated CD4+ HLADR+ T-cells normalized by 9 months and remained above normal value till 24 months. Finally, naives B-cells (CD19+ CD27-) were within the normal range by 6 months and then above normal value till 24 months while memory B-cells remained under normal range during the follow-up time (figure 1).
Our prospective series involved patients who were alive and disease free more than 2 years after transplantation using myeloablative conditioning. Patients who underwent transplantation after a reduced-intensity conditioning regimen or who were grafted with cord blood were excluded because both situation display different and specific immune reconstitution timing. Of note, patients with worst immune reconstitution post-transplant have thus been virtually excluded from this study because of potential death from early infection /GVHD or later disease relapse/progression. Furthermore it's impossible to know if late infections or antimicrobial prophylaxes, chronic GvHD or its treatment by immunosuppressive therapy, could influence (and if yes to what extent) some of the biological parameters we measured because these parameters are confounding factors. Other authors have reported that CD8 T cells early post-transplant consist largely of memory/effector cells with slow recovery of naïve CD8 cells (20, 21) . The expansion of the CD8+DR+ subset is rather suggestive of activated CD8+ cells primed toward allogeneic and infectious antigen. Other authors have reported that early CD4 regeneration is associated with expression of CD45RO, and HLA-DR and less frequent expression of CD28, CD45RA [review in (1-3)]. However although classically recovering by one year our results do show that, with the exception of activated DR+ cells, other subsets remain profoundly affected even 2 years post transplant. We especially focused our analysis on B-cell reconstitution in this cohort of patients. Storek and coworkers have previously reported data suggesting that recapitulation of normal lymphoid ontogeny occurs during reconstitution of B lymphocytes [ (11, 14, 15) ]. These authors reported that a relatively rapid initial rise in naive B cells is followed by a slow recovery of memory B cells.
Impact of GvHD on long-term reconstitution
In this selected population, acute GvHD severity did not influence significantly Tlymphocytes subsets (data not shown). However, total B cells were significantly lower at 3 (p=0.001) and 6 months (P=0.004) in patients who previously developed grade II-IV acute GvHD. The same correlation between acute GvHD and CD19+CD5+
© F e r r a t a S t o r t i F o u n d a t i o n (P=0.003 at 3 months), and naïve B cells (P=0.02 and P=0.007 at 3 and 6 months) was found. We then studied the influence of the extensive form of c.GvHD on the long-term immune recovery. A long lasting lymphopenia (till 24 months) was observed in patients who developed extensive c.GvHD. CD4 and CD8 T-cells were affected by c.GvHD. This was particularly true for memory and competent CD8 cells. The CD4 T-cell subsets were most affected, with significant decrease of naïve and competent CD4+ cells at 12 and 24 months (data not shown). But the biggest impact of extensive c.GvHD was found on B cells and B cell subsets (figure 2). CD 19+ and CD19+/CD5+ B cells were significantly decreased at 6 (P=0.001), 12 (P=0.005) and 24 months (P=0.02); memory B cell counts were decreased at 12 (P=0.005) and 24 months (P=0.003) (figure 2) while naïve B cells remained lower till 12 months (P=0.003).
The magnitude of chronic GvHD impact on B-cell subsets recovery has not been well described, to date. Impact on both naive CD4 and B-cell subsets could explain defaults in T-B cooperation and consequently in B-cell switch, maturation and Ig production. Recently Greinix and coworkers (22) 
Impact of the immune biological defect on late infections rate
Finally we focused our attention on late infections (occurring after 3 months post transplantation). Twenty-eight infections were recorded among 22 patients from 3 months to 2-year post transplantation. During the first year, 13 severe bacterial infections, 3 fungal infections and 3 CMV-reactivation were recorded, while between the 1 st and the 2 nd year only 4 severe bacterial infections developed. The cumulative incidence of first late infection was 14% at 3 years ( figure 2A supplementary data  online) . By univariate analysis c.GvHD and the source of cells marginally affected this cumulative incidence: 10 vs. 18% at 6OO days in patients with no c.GvHD as compared to patients with c.GvHD (P=0.06). Other tested factors including, the source of cell [11% with bone marrow vs. 22% with peripheral blood (P=0.08)]. Age (older vs. than 25 years median age), donor type (sibling vs. others), and TBI did not significantly influenced the cumulative incidence of infections. None of these factors remained significant by multivariate analyses.
The relation, if any, between any cell subsets at different time point post-transplant and their association with late infections, were tested using Cox modeling to take into account few infectious events and the large number of analyzed cell subsets. In univariate analyses done at 3, 6, 12 and 24 months, low NK cells count at 3 and 6 months marginally accounted for increased risk of infection (p=.08 and p=.01 respectively). These results remained significant at 6 months (p=.01, HR=4.96, CI95%: 1.45-17.0) in multivariate analyses including age, source of cells and c.GvHD as covariates. However, increased infection was linked with the use of peripheral blood grafts 3 months (P=0.01, HR=3.52, CI95%: 1.32-9.15) 12 months (P =0.05, HR=2.5, CI95%=1.01-6.21) and 24 months (P=0.03, HR= 2.97, CI95%: 1.1-8.0). None of the CD4+ or CD8+ T-cell subsets was linked to increased risk of infections. Only B lymphocytes counts at 12 and 24 months were associated with late infections. These results were found by univariate (P=0.02 and 0.001, respectively) and figure 2b supplementary data online) .
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The spectrum of late infection (beyond a year) mainly includes bacterial infections (19) . The B-cell defects we describe in addition to low gamma globulin levels in patients with c.GvHD both explain these long-term bacterial infections. As stated in the methods section, IV-Ig prophylaxis is not our policy since we previously reported in a double blinded randomized study their lack of efficacy (23) . However, Ig supplementation in patients with low Ig levels and recurrent infections was systematically done.
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Severe infections; definitions
In brief: Severe bacterial infections requiring hospitalization including pneumonia, sepsis syndrome, pyelonephritis, meningitis, and ostomyelitis. Bronchitis, sinusitis, and cystitis were excluded. Of note, undocumented pneumonia or sepsis syndromes or septic shock that resolved after antibiotic treatment were considered as bacterial. Viral infections included all documented invasive viral infections requiring hospitalization, namely infections related to Herpes simplex virus, adenovirus, respiratory syncitial virus (RSV), human papilloma virus (HPV) in an extensive form, Epstein Barr Virus (EBV), cytomegalovirus (CMV). In addition, we collected less severe, but more common viral infections as VZV and viral hepatitis (B or C [HBV or HCV]). We did not include benign, presumably viral, or upper airway infection. Invasive fungal infections include those involving the lung, central nervous system, or septicemia. © F e r r a t a S t o r t i F o u n d a t i o n
